Graeme Bell
2017
In 2017, Graeme Bell earned a total compensation of $3.8M as Executive Vice President, Chief Financial Officer at Intellia Therapeutics.
Compensation breakdown
| Bonus | $178,480 |
|---|---|
| Option Awards | $3,170,414 |
| Salary | $400,000 |
| Other | $49,018 |
| Total | $3,797,912 |
Bell received $3.2M in option awards, accounting for 83% of the total pay in 2017.
Bell also received $178.5K in bonus, $400K in salary and $49K in other compensation.
Rankings
In 2017, Graeme Bell's compensation ranked 2,739th out of 14,666 executives tracked by ExecPay. In other words, Bell earned more than 81.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,739 out of 14,666 | 81st |
Division Manufacturing | 946 out of 5,768 | 84th |
Major group Chemicals And Allied Products | 249 out of 2,074 | 88th |
Industry group Drugs | 189 out of 1,730 | 89th |
Industry In Vitro and In Vivo Diagnostic Substances | 4 out of 72 | 94th |
Source: SEC filing on April 17, 2018.
Bell's colleagues
We found three more compensation records of executives who worked with Graeme Bell at Intellia Therapeutics in 2017.